Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsi... — FDA record D-0913-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jul 5, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28
Reason
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA Inc
Quantity
180 bottles
Agency-reported status
Terminated
Source record identifier
D-0913-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLot # 100037220, Exp 10/2024

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Jul 19, 2023
Recall initiation date
Jul 5, 2023
Center classification date
Jul 11, 2023
Termination date
Jan 10, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records